GynecologyGynecologyГинекология2079-56962079-5831Consilium Medicum28611ArticlesСтатьиResearch ArticleImmunotherapy for recurrent miscarriage due to alloimmune reasonsИммунотерапия при привычном выкидыше, обусловленном аллоиммунными причинамиSaribegovaV AСарибеговаВ А

аспирант, 2-е отд-ние акушерское патологии беременности ФГБУ «НЦАГиП им. акад. В.И.Кулакова»

saribegova_v@rambler.ruTetruashviliN KТетруашвилиН К

д-р мед. наук, рук. 2-го отд-ния акушерского патологии беременности ФГБУ «НЦАГиП им. акад. В.И.Кулакова»

KrechetovaL VКречетоваЛ В

рук. лаб. клинической иммунологии ФГБУ «НЦАГиП им. акад. В.И.Кулакова»

AgadzhanovaA AАгаджановаА А

вед. науч. сотр. 2-го отд-ния акушерского патологии беременности ФГБУ «НЦАГиП им. акад. В.И.Кулакова»

V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationФГБУ «Научный центр акушерства, гинекологии и перинатологии им. В.И.Кулакова» Минздрава России15022017191VOL 19, NO1 (2017)ТОМ 19, №1 (2017)515509042020Copyright ©; 2017, Consilium MedicumCopyright ©; 2017, ООО "Консилиум Медикум"2017Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://gynecology.orscience.ru/2079-5831/article/view/28611

The article presents the current understanding of the pathogenetic mechanisms of habitual abortion realization of alloimmune genesis and proposed methods of immunotherapy. The mechanisms of the impact and effectiveness of various drugs and cell therapies.

В статье приведены современные представления о патогенетических механизмах реализации привычного выкидыша аллоиммунного генеза и предлагаемые методы иммунотерапии. Рассмотрены механизмы воздействия и эффективность разных лекарственных и клеточных методов лечения.

habitual miscarriageimmunocytotherapyprogesteronedydrogesteroneT-regulatory cellsnatural killer cellstolerogenic molecule CD200cytokinesпривычный выкидышиммуноцитотерапияпрогестерондидрогестеронТ-регуляторные клеткинатуральные киллерытолерогенная молекула CD200цитокиныЛевкович М.А., Линде В.А., Андреева В.О. и др. Иммуно - гормональные взаимодействия в генезе невынашивания беременности ранних сроков. Акушерство и гинекология. 2012; 8 (1): 10-4.Hannan. N.J. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia. 2011. http://www.ncbi.nlm.nih.gov/pubmedWinger E.E and Jane L. Reed Reccurent Pregnancy Loss, 2nd Edition (CRС Press, 2015) Should Immunotherapy Be Used? Lymphocyte Immunization Therapy.Yes 249.Early Pregnancy. Edited by R.G. Farquharson, Stephenson M.D. Cambridge University Press, 2012. Cambridge Books Online http://ebooks.cambridge.org/ Book DOI: http://dx.doi.org/10.1017/CBO9780511777851Lee S.K, Kim J.Y, Lee M et al. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 2012; 67: 311-5.Li J, Chen Y, Liu C et al. Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: A systematic review and a meta - analysis. Am J Reprod Immunol 2013; 704: 34-7.Reznikoff-Etievant M.F, Durieux I, Lobet R et al. Immunologic abortion and its treatment by immunotherapy. Rev Fr Transfus Immunohematol 1986; 29 (3): 135-48.Сухих Г.Т., Ванько Л.В. Иммунология беременности. М.: Издательство РАМН, 2003: 339-92.Haas D.M, Ramsey P.S. Progestogen for preventing miscarriage. Editorial Group: Cochrane Pregnancy and Childbirth Group.Schleussner E. Impact of the antiphospholipid syndrome on complications during pregnancy Transfus Med Hemother 2006; 33 (6): 486-92.Ralph S.G, Rutherford A.J, Wilson J.D. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ 1999; 319 (7204): 220-3.Szekeres-Bartho J, Barakonyi A, Polgar B et al. The Role of g/d Cells in Progesterone - Mediated Immunomodulation During Pregnancy: A Review. Am J Reprod Immunol 1999; 42 (1): 44-8.Посиссева Л.В., Малышкина А.И., Бойко Е.Л. и др. Реабилитация репродуктивного здоровья супружеских пар с невынашиванием беременности. Иваново: Иваново, 2008.Beer A et al. New horizons in the diagnosis, evaluation and therapy of recurrent spontaneous abortion. Clin Obstet Gynaecol 1986; 13 (1): 115-24.Robertson S.A, Sharkey D.J. The Male Role in Pregnancy Loss and Embryo Implantation Failure. 2001.Карп Г. Систематический обзор применения дидрогестерона для лечения угрозы прерывания беременности. Здоровье женщины. 2013; 1: 46-56.Saccone G, Schoen C, Franasiak J.M et al. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta - analysis of randomized, controlled trials. Fertil Steril 2017; 107 (2): 430-8.Brogin Moreli J. Interleukin 10 and Tumor Necrosis Factor - Alpha in Pregnancy: Aspects of Interest in Clinical Obstetrics. ISRN Obstet Gynecol 2012; 230-42. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3302063/Kheshtchin N, Gharagozloo M, Andalib A et al. The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy. Am J Reprod Immunol 2010; 64 (2): 104-12.Park D.W, Lee H.J, Park C.W et al. Peripheral blood NK cells reflect changes in decidual NK cells in women with recurrent miscarriages. Am J Reprod Immunol 2010; 63 (2): 173-80.Wang W.J, Hao C.F, Lin Q.D. Dysregulation of macrophage activation by decidual regulatory T cells in unexplained recurrent miscarriage patients. J Hyperlink 2011; 92 (1-2): 97-102.Katano K, Suzuki S, Ozaki Y et al. Peripheral natural killer cell activity as a predictor of recurrent pregnancy loss: A large cohort study. Fertil Steril 2013; 100: 1629-34.Kaczmarek A, Vandenabeele P, Krysko D.V. Necroptosis: The release of damage - associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209-23.Малышкина А.И., Можаева А.И., Воронин Д.Н. Особенности реакций врожденного иммунитета у женщин с угрозой прерывания беременности на ранних сроках. Рос. иммунол. журн. 2010; 4: 407-8.Liang P, Mo M, Li G.G et al. Comprehensive analysis of peripheral blood lymphocytes in 76 women with recurrent miscarriage before and after lymphocyte immunotherapy. Am J Reprod Immunol 2012; 68: 164-74.Li J, Chen Y, Liu C et al. Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: A systematic review and a meta - analysis. Am J Reprod Immunol 2013; 704: 34-7.Reccurent pregnancy loss: causes, controversies and treatment. Ed. by Carp Howard J.A. Informa UK ltd, 2007.Vacca P, Cantoni C, Vitale M et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc Natl Acad Sci USA 2010; 107 (26): 11918-23.Raj Rai. Debate: Should immunotherapy be used? No. In: Carp H.J.A., ed. Recurrent pregnancy loss: сauses, controversies, and treatment. 2nd ed. CRС Press; 2014: 265.Trabanelli S, Ocadlikova D, Evangelisti C et al. Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3-dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance. Curr Med Chem 2011; 18 (15): 2234-9.Крошкина Н.В., Малышкина А.И., Можаева Т.А. Особенности функционального состояния клеток макрофагального ряда у женщин с невынашиванием беременности ранних сроков. Вестн. уральской медицинской академической науки. 2010; 2 (1): 154-5.Hayakawa S, Karasaki-Suzuki M, Itoh T et al. Effects of paternal lymphocyte immunization on peripheral Th1:Th2 balance and TCR Vb and Vg repertoire usage of patients with recurrent spontaneous abortions. AJRI 2000; 43: 107-14.Kwiatek M, Gęca T, Krzyżanowski A et al. Public Peripheral dendritic cells and CD4+CD25+Foxp3+ regulatory T cells in the first trimester of normal pregnancy and in women with recurrent miscarriage. PLoS One 2015; 10 (5): e0124747.Wegmann T.G, Lin H, Guilbert L, Mosmann T.R: Bidirectional cytokine interactions in the maternal - fetal relachionship: is successful pregnancy a Th2 phenomen. Immunol Today 1993; 14: 353-6.Romero R, Gotsch F, Pineles B, Kuzanovic J.P. Inflamation in pregnancy its role in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007; (II): 194-202.Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011; 1221: 80-7.Saito S, Shima T, Nakashima A et al. What is the role of regulatory T cells in the success of implantation and early pregnancy? Assist Reprod Genet 2007; 24: 379-86.Clark D.A. Cell surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human reccurent pregnancy loss. Am J Reprod Immunol 2009; 61: 75-84.Clark D.A, Wong K, Banwatt D et al. CD200-dependent and nonCD200-dependent pathways of NK cell suppression by human IVIG. J Assist Reprod Genet 2008; 25 (2-3): 67-72.Gharesi-Fard B, Zolghadri J, Foroughinia L et al. Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA). Iran J Immunol 2007; 4 (3): 173-8.Pandey M.K, Agrawal S. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. Int Immunopharmacol 2004; 4: 289-98.Kheshtchin N, Gharagozloo M, Andalib A et al.The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy. Am J Reprod Immunol 2010; 64 (2): 104-12.Beaman K.D, Ntrivalas E, Mallers T.M et al. Immune Etiology of Recurrent Pregnancy Loss and Its Diagnosis. North Chicago, IL, USA, 2015.Сидельникова В.М. Подготовка и ведение беременности у женщин с привычным невынашиванием: метод. пособия и клин. рекомендации. М: МЕДпресс-информ, 2011.Check J.H. A practical approach to the prevention of miscarriage: part 2-active immunotherapy. Clin Exp Obstet Gynecol 2010; 37 (1): 5-9.Yang H, Qiu L, Di W et al. Proportional change of CD4+CD25+ regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil Steril 2009; 92 (1): 301-5.Khonina N.A, Broitman E.V, Shevela E.Y et al. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch Gynecol Obstet 2013; 288 (4): 933-7.Nonaka T, Takakuwa K, Ooki I et al. Results of immunotherapy for patients with unexplained primary recurrent abortions -- prospective non - randomized cohort study. Am J Reprod Immunol 2007; 58 (6): 530-6.Wilczyński J.R, Radwan P, Tchórzewski H, Banasik M. Immunotherapy of patients with recurrent spontaneous miscarriage and idiopathic infertility: does the immunization - dependent Th2 cytokine overbalance really matter? Arch Immunol Ther Exp (Warsz) 2012; 60 (2): 151-60.Duckitt K, Qureshi A. Recurrent miscarriage. Clin Evid (Online) 2011; 2011. pii: 1409.Check J.H, Arwitz M, Gross J et al. Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF). Am J Reprod Immunol 1997; 37 (1): 17-20.